Literature DB >> 29179130

Predictive bioinformatics identifies novel regulators of proliferation in a cancer stem cell model.

Evan Fields1, Jonathan D Wren2, Constantin Georgescu2, John R Daum1, Gary J Gorbsky3.   

Abstract

The cancer stem cell model postulates that tumors are hierarchically organized with a minor population, the cancer stem cells, exhibiting unlimited proliferative potential. These cells give rise to the bulk of tumor cells, which retain a limited ability to divide. Without successful targeting of cancer stem cells, tumor reemergence after therapy is likely. However, identifying target pathways essential for cancer stem cell proliferation has been challenging. Here, using a transcriptional network analysis termed GAMMA, we identified 50 genes whose correlation patterns suggested involvement in cancer stem cell division. Using RNAi depletion, we found that 21 of these target genes showed preferential growth inhibition in a breast cancer stem cell model. More detailed initial analysis of 6 of these genes revealed 4 with clear roles in the fidelity of chromosome segregation. This study reveals the strong predictive potential of transcriptional network analysis in increasing the efficiency of successful identification of novel proliferation dependencies for cancer stem cells.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer stem cells; Cell cycle; Cell division; Chromosome instability; Mitosis

Mesh:

Substances:

Year:  2017        PMID: 29179130      PMCID: PMC5899939          DOI: 10.1016/j.scr.2017.11.009

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  37 in total

1.  Olfactomedin 4 defines a subset of human neutrophils.

Authors:  Stine N Clemmensen; Christina T Bohr; Sara Rørvig; Andreas Glenthøj; Helena Mora-Jensen; Elisabeth P Cramer; Lars C Jacobsen; Maria T Larsen; Jack B Cowland; Julia T Tanassi; Niels H H Heegaard; Jonathan D Wren; Asli N Silahtaroglu; Niels Borregaard
Journal:  J Leukoc Biol       Date:  2011-12-20       Impact factor: 4.962

2.  Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.

Authors:  Loren Michel; Elena Diaz-Rodriguez; Gopeshwar Narayan; Eva Hernando; Vundavalli V V S Murty; Robert Benezra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

Review 3.  CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.

Authors:  Karin Williams; Karan Motiani; Premkumar Vummidi Giridhar; Susan Kasper
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

4.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

5.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

Authors:  Tan A Ince; Andrea L Richardson; George W Bell; Maki Saitoh; Samuel Godar; Antoine E Karnoub; James D Iglehart; Robert A Weinberg
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

6.  Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors.

Authors:  Alain D Silk; Lauren M Zasadil; Andrew J Holland; Benjamin Vitre; Don W Cleveland; Beth A Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-16       Impact factor: 11.205

7.  A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.

Authors:  Fabio Petrocca; Gabriel Altschuler; Shen Mynn Tan; Marc L Mendillo; Haoheng Yan; D Joseph Jerry; Andrew L Kung; Winston Hide; Tan A Ince; Judy Lieberman
Journal:  Cancer Cell       Date:  2013-08-12       Impact factor: 31.743

8.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

9.  How Taxol/paclitaxel kills cancer cells.

Authors:  Beth A Weaver
Journal:  Mol Biol Cell       Date:  2014-09-15       Impact factor: 4.138

10.  Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.

Authors:  A E Witt; C-W Lee; T I Lee; D J Azzam; B Wang; C Caslini; F Petrocca; J Grosso; M Jones; E B Cohick; A B Gropper; C Wahlestedt; A L Richardson; R Shiekhattar; R A Young; T A Ince
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more
  5 in total

1.  Differential gene expression and network analysis in head and neck squamous cell carcinoma.

Authors:  Insan Habib; Farah Anjum; Taj Mohammad; Md Nayab Sulaimani; Alaa Shafie; Mazen Almehmadi; Dharmendra Kumar Yadav; Sukhwinder Singh Sohal; Md Imtaiyaz Hassan
Journal:  Mol Cell Biochem       Date:  2022-02-10       Impact factor: 3.396

2.  Oklahoma Nathan Shock Aging Center - assessing the basic biology of aging from genetics to protein and function.

Authors:  Holly Van Remmen; Willard M Freeman; Benjamin F Miller; Michael Kinter; Jonathan D Wren; Ann Chiao; Rheal A Towner; Timothy A Snider; William E Sonntag; Arlan Richardson
Journal:  Geroscience       Date:  2021-10-04       Impact factor: 7.713

3.  Characterization of cxorf21 Provides Molecular Insight Into Female-Bias Immune Response in SLE Pathogenesis.

Authors:  Valerie M Harris; Kristi A Koelsch; Biji T Kurien; Isaac T W Harley; Jonathan D Wren; John B Harley; R Hal Scofield
Journal:  Front Immunol       Date:  2019-10-21       Impact factor: 7.561

4.  ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin.

Authors:  Mohammad Kamran; Udayan Bhattacharya; Mohamed Omar; Luigi Marchionni; Tan A Ince
Journal:  NPJ Breast Cancer       Date:  2022-08-29

5.  CSAG1 maintains the integrity of the mitotic centrosome in cells with defective p53.

Authors:  Hem Sapkota; Jonathan D Wren; Gary J Gorbsky
Journal:  J Cell Sci       Date:  2020-05-27       Impact factor: 5.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.